$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained-release formulation of methylphenidate 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/00
출원번호 US-0679875 (1996-07-15)
우선권정보 GB-0014451 (1995-07-14)
발명자 / 주소
  • Baker Helen Frances,GBX
  • Gilbert Julian Clive,GBX
출원인 / 주소
  • Medeva Europe Limited, GBX
대리인 / 주소
    Saliwanchik, Lloyd & Saliwanchik
인용정보 피인용 횟수 : 120  인용 특허 : 2

초록

The subject invention pertains to a sustained-release formulation of d-threo-methylphenidate (dtmp). The subject invention also pertains to methods for treating disorders using a sustained-release formulation comprising d-threo-methylphenidate.

대표청구항 ▼

[ We claim:] [1.] A method for treating a human subject having a disorder capable of treatment with methylphenidate, which comprises administering to said subject a sustained-release formulation comprising an effective amount of d-threo-methylphenidate, wherein said sustained-release formulation is

이 특허에 인용된 특허 (2)

  1. Bencherif Merouane (5437-B Countryside Dr. Winston-Salem NC 27105) Caldwell William S. (1270 Yorkshire Rd. Winston-Salem NC 27106) Dull Gary M. (1175 Sequoia Dr. Lewisville NC 27023) Lippiello Patric, Pharmaceutical compositions for the treatment of central nervous system disorders.
    상세보기
  2. Mueller Karl F. (New York NY) Good William R. (Yorktown Heights NY), Water-insoluble hydrophilic copolymers.
    상세보기

이 특허를 인용한 특허 (120)

  1. Mehta, Ketan; Tu, Yu-Hsing, Clonidine formulation.
    상세보기
  2. Richards,Andrew John McGlashan; Pope,Nicholas Robert, Composition comprising methylphenidate and another drug.
    상세보기
  3. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  4. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  5. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  6. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  7. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  8. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  9. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  10. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  11. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
    상세보기
  12. Krishnamurthy, Thinnayam N.; Darke, Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
    상세보기
  13. Krishnamurthy, Thinnayam N.; Darke, Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
    상세보기
  14. Krishnamurthy, Thinnayam N.; Darke, Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
    상세보기
  15. Krishnamurthy,Thinnayam N.; Darke,Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
    상세보기
  16. Krishnamurthy,Thinnayam N.; Darke,Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
    상세보기
  17. Thinnayam N. Krishnamurthy CA; Andrew Darke CA, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
    상세보기
  18. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
    상세보기
  19. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  20. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  21. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  22. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  23. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  24. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  25. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  26. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  27. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  28. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  29. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  30. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  31. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  32. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  33. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
    상세보기
  34. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  35. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  36. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  37. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  38. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  39. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  40. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
    상세보기
  41. Goldenheim, Paul D.; Sackler, Richard S.; Krishnamurthy, Thinnayam N.; Darke, Andrew; Oshlack, Benjamin, Controlled/modified release oral methylphenidate formulations.
    상세보기
  42. Goldenheim,Paul D.; Sackler,Richard S.; Krishnamurthy,Thinnayam N.; Darke,Andrew; Oshlaci,Benjamin, Controlled/modified release oral methylphenidate formulations.
    상세보기
  43. Mehta, Atul M.; Zeitlin, Andrew L.; Dariani, Maghsoud M., Delivery of multiple doses of medications.
    상세보기
  44. Mehta,Atul M.; Zeitlin,Andrew L.; Dariani,Maghsoud M., Delivery of multiple doses of medications.
    상세보기
  45. Baldessarini Ross ; Campbell Alexander, Method of dopamine inhibition using l-threo-methylphenidate.
    상세보기
  46. Kamal K. Midha BM; Martin Teicher ; Vijai Kumar, Method of treating depression using 1-threo-methylphenidate.
    상세보기
  47. Midha Kamal K.,BMX ; Teicher Martin ; Kumar Vijai, Method of treating depression using l-threo-methylphenidate.
    상세보기
  48. Lickrish, David; Zhang, Feng, Method of treatment of attention deficit hyperactivity disorder.
    상세보기
  49. Lickrish, David; Zhang, Feng, Methods and compositions for treatment of attention deficit disorder.
    상세보기
  50. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
    상세보기
  51. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
    상세보기
  52. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
    상세보기
  53. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
    상세보기
  54. Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
    상세보기
  55. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richar, Methods and devices for providing prolonged drug therapy.
    상세보기
  56. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richard G., Methods and devices for providing prolonged drug therapy.
    상세보기
  57. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah, Methods and devices for providing prolonged drug therapy.
    상세보기
  58. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D; Hatamkhany, Zahedeh; Weyers, Richard G; Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D., Methods and devices for providing prolonged drug therapy.
    상세보기
  59. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
    상세보기
  60. Madras, Bertha K.; Fischman, Alan J.; Meltzer, Peter C., Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level.
    상세보기
  61. Madras,Bertha K.; Fischman,Alan J.; Meltzer,Peter C., Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level.
    상세보기
  62. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
    상세보기
  63. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
    상세보기
  64. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
    상세보기
  65. Jerome B. Zeldis ; Herbert Faleck ; Vikram Khetani, Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate.
    상세보기
  66. Zeldis,Jerome B; Faleck,Herbert J.; Khetani,Vikram; Zeitlin,Andrew L.; Dariani,Maghsoud M.; Sterling,David, Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate.
    상세보기
  67. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
    상세보기
  68. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
    상세보기
  69. Krishnamurthy, Thinnayam N.; Darke, Andrew, Methods of preparing oral controlled release formulations.
    상세보기
  70. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
    상세보기
  71. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
    상세보기
  72. Krishnamurthy, Thinnayam N.; Darke, Andrew, Methods of treating attention deficit hyperactivity disorder.
    상세보기
  73. Krishnamurthy, Thinnayam N.; Darke, Andrew, Methods of treating attention deficit hyperactivity disorder.
    상세보기
  74. Lickrish, David; Zhang, Feng, Methods of treatment of attention deficit hyperactivity disorder.
    상세보기
  75. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  76. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  77. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  78. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  79. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  80. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  81. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
    상세보기
  82. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug - ion exchange resin complexes.
    상세보기
  83. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  84. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  85. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  86. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  87. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  88. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  89. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  90. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  91. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  92. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  93. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  94. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
    상세보기
  95. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug—ion exchange resin complexes.
    상세보기
  96. Devane, John G.; Stark, Paul; Fanning, Niall M. M., Multiparticulate modified release composition.
    상세보기
  97. Devane, John G.; Stark, Paul; Fanning, Niall M. M.; Rekhi, Gurvinder Singh, Multiparticulate modified release composition.
    상세보기
  98. Devane, John G; Stark, Paul; Fanning, Niall M. N.; Rekhi, Gurvinder Singh; Jenkins, Scott A.; Liversidge, Gary, Nanoparticulate and controlled release compositions comprising cefditoren.
    상세보기
  99. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu Xiu; Xie, Jianbo, Oral controlled release dosage form.
    상세보기
  100. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu Xiu; Xie, Jianbo, Oral controlled release dosage form.
    상세보기
  101. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu-Xiu; Xie, Jianbo, Oral controlled release dosage form.
    상세보기
  102. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
    상세보기
  103. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
    상세보기
  104. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
    상세보기
  105. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
    상세보기
  106. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
    상세보기
  107. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
    상세보기
  108. Midha Kamal K.,BMX ; Teicher Martin H., Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant.
    상세보기
  109. Kamal K. Midha BM; Theodore L. Iorio ; Shubha Chungi, Pharmaceutical dosage form for pulsatile delivery of methylphenidate.
    상세보기
  110. Midha, Kamal K., Pharmaceutical dosage form for pulsatile delivery of methylphenidate.
    상세보기
  111. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
    상세보기
  112. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
    상세보기
  113. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
    상세보기
  114. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
    상세보기
  115. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
    상세보기
  116. Andrew L. Zeitlin ; Maghsoud M. Dariani, Phenidate drug formulations having diminished abuse potential.
    상세보기
  117. Zeitlin, Andrew L.; Dariani, Maghsoud M., Phenidate drug formulations having diminished abuse potential.
    상세보기
  118. Khetani,Vikram; Luo,Yalin; Ramaswamy,Sowmianarayanan, Processes and intermediates for resolving piperidyl acetamide stereoisomers.
    상세보기
  119. Krsek, George, Pulse dosage formulations of methylphenidate and method to prepare same.
    상세보기
  120. Fleshner-Barak, Moshe; Lerner, E. Itzhak; Rosenberger, Vered; Dahan, Mazal; Makov, Yisrael, Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition.
    상세보기

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로